Literature DB >> 27521622

Etiological associations and outcome predictors of acute electroencephalography in childhood encephalitis.

Shekeeb S Mohammad1, Samantha M Soe2, Sekhar C Pillai3, Margherita Nosadini4, Elizabeth H Barnes5, Deepak Gill6, Russell C Dale7.   

Abstract

OBJECTIVES: To examine EEG features in a retrospective 13-year cohort of children with encephalitis.
METHODS: 354 EEGs from 119 patients during their admission were rated blind using a proforma with demonstrated inter-rater reliability (mean k=0.78). Patients belonged to 12 etiological groups that could be grouped into infectious and infection-associated (n=47), immune-mediated (n=36) and unknown (n=33). EEG features were analyzed between groups and for risk of abnormal Liverpool Outcome Score and drug resistant epilepsy (DRE) at last follow up.
RESULTS: 86% children had an abnormal first EEG and 89% had at least one abnormal EEG. 55% had an abnormal outcome, and 13% had DRE after median follow-up of 7.3years (2.0-15.8years). Reactive background on first EEGs (9/11, p=0.04) and extreme spindles (4/11, p<0.001) distinguished patients with anti-N-Methyl-d-Aspartate Receptor encephalitis. Non-reactive EEG background (48% first EEGs) predicted abnormal outcome (OR 3.8, p<0.001). A shifting focal seizure pattern, seen in FIRES (4/5), anti-voltage gated potassium channel (2/3), Mycoplasma (1/10), other viral (1/10) and other unknown (1/28) encephalitis, was most predictive of DRE after multivariable analysis (OR 11.9, p<0.001).
CONCLUSIONS: Non-reactive EEG background and the presence of shifting focal seizures resembling migrating partial seizures of infancy are predictors of abnormal outcome and DRE respectively in childhood encephalitis. SIGNIFICANCE: EEG is a sensitive but non-discriminatory marker of childhood encephalitis. We highlight the EEG features that predict abnormal outcome and DRE.
Copyright © 2016 International Federation of Clinical Neurophysiology. All rights reserved.

Entities:  

Keywords:  Autoimmune; DRE; EEG; Encephalitis; FIRES; Herpes; NMDAR

Mesh:

Year:  2016        PMID: 27521622     DOI: 10.1016/j.clinph.2016.07.014

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  7 in total

Review 1.  Sleep Disturbances Associated with Neurological Autoimmunity.

Authors:  Michelle F Devine; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

Review 2.  Diagnosis and Management of Acute Encephalitis in Children.

Authors:  Satinder Aneja; Suvasini Sharma
Journal:  Indian J Pediatr       Date:  2018-09-19       Impact factor: 5.319

3.  Prognostic evaluation of child patients with infectious encephalitis through AEEG and REEG.

Authors:  Yujun Lin; Ge Zhang; Yan Wang; Jianjun Chai; Xiufang Jiang; Cong Li; Hui Xu
Journal:  Exp Ther Med       Date:  2018-10-19       Impact factor: 2.447

4.  Incidence of Childhood Meningoencephalitis in Children With a Suspected Meningoencephalitis in the Netherlands.

Authors:  Dirkje de Blauw; Andrea H L Bruning; Katja C Wolthers; Anne-Marie van Wermeskerken; Maarten H Biezeveld; Joanne G Wildenbeest; Dasja Pajkrt
Journal:  Pediatr Infect Dis J       Date:  2022-04-01       Impact factor: 3.806

Review 5.  A Comprehensive Review of Pediatric Acute Encephalopathy.

Authors:  George Imataka; Shigeko Kuwashima; Shigemi Yoshihara
Journal:  J Clin Med       Date:  2022-10-07       Impact factor: 4.964

6.  Value and mechanisms of EEG reactivity in the prognosis of patients with impaired consciousness: a systematic review.

Authors:  Eric Azabou; Vincent Navarro; Nathalie Kubis; Martine Gavaret; Nicholas Heming; Alain Cariou; Djillali Annane; Fréderic Lofaso; Lionel Naccache; Tarek Sharshar
Journal:  Crit Care       Date:  2018-08-02       Impact factor: 9.097

7.  Epidemiology and Etiology of Severe Childhood Encephalitis in The Netherlands.

Authors:  Dirkje de Blauw; Andrea H L Bruning; C B E Busch; Lisa M Kolodziej; N J G Jansen; J B M van Woensel; Dasja Pajkrt
Journal:  Pediatr Infect Dis J       Date:  2020-04       Impact factor: 3.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.